FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136015194> ?p ?o ?g. }

• W3136015194 abstract "Price gouging in the US pharmaceutical drug industry goes back more than three decades. In 1985 US Representative Henry Waxman, chair of the House Subcommittee on Health and the Environment, accused the pharmaceutical industry of ``gouging the American public`` with ``outrageous`` price increases, driven by ``greed on a massive scale.`` Even in the wake of the many Congressional inquiries that have taken place since the 1980s, including one inspired by the extortionate prices that Gilead Sciences has placed on its Hepatitis-C drugs Sovaldi since 2013 and Harvoni since 2014, the US government has not seen fit to regulate drug prices. UK Prescription Price Regulation Scheme data for 1996 through 2010 show that, while drug prices in other advanced nations were close to the UK`s regulated prices, those in the United States were between 74 percent and 181 percent higher. Medecins Sans Frontieres (MSF) has produced abundant evidence that US drug prices are by far the highest in the world. The US pharmaceutical industry`s invariable response to demands for price regulation has been that it will kill innovation. US drug companies claim that they need higher prices than those that prevail elsewhere so that the extra profits can be used to augment R&D spending. The result, they contend, is more drug innovation that benefits the United States, and indeed the whole world. It is a compelling argument, until one looks at how major US pharmaceutical companies actually use the profits that high drug prices generate. In the name of ``maximizing shareholder value`` (MSV), pharmaceutical companies allocate the profits generated from high drug prices to massive repurchases, or buybacks, of their own corporate stock for the sole purpose of giving manipulative boosts to their stock prices. Incentivizing these buybacks is stock-based compensation that rewards senior executives for stock-price ``performance.`` Like no other sector, the pharmaceutical industry puts a spotlight on how the political economy of science is a matter of life and death. In this paper, we invoke ``the theory of innovative enterprise`` to explain how and why high drug prices restrict access to medicines and undermine medical innovation. An innovative enterprise seeks to develop a high-quality product that it can sell to the largest possible market at the most affordable price. In sharp contrast, the MSV-obsessed companies that dominate the US drug industry have become monopolies that restrict output and raise price. These companies need to be regulated." @default.
• W3136015194 created "2021-03-29" @default.
• W3136015194 creator A5011140625 @default.
• W3136015194 creator A5029107647 @default.
• W3136015194 creator A5055987480 @default.
• W3136015194 creator A5075667875 @default.
• W3136015194 creator A5076988874 @default.
• W3136015194 date "2017-01-01" @default.
• W3136015194 modified "2023-09-27" @default.
• W3136015194 title "US Pharma`s Financialized Business Model" @default.
• W3136015194 hasPublicationYear "2017" @default.
• W3136015194 type Work @default.
• W3136015194 sameAs 3136015194 @default.
• W3136015194 citedByCount "0" @default.
• W3136015194 crossrefType "posted-content" @default.
• W3136015194 hasAuthorship W3136015194A5011140625 @default.
• W3136015194 hasAuthorship W3136015194A5029107647 @default.
• W3136015194 hasAuthorship W3136015194A5055987480 @default.
• W3136015194 hasAuthorship W3136015194A5075667875 @default.
• W3136015194 hasAuthorship W3136015194A5076988874 @default.
• W3136015194 hasConcept C10138342 @default.
• W3136015194 hasConcept C120757647 @default.
• W3136015194 hasConcept C126322002 @default.
• W3136015194 hasConcept C138885662 @default.
• W3136015194 hasConcept C144133560 @default.
• W3136015194 hasConcept C162324750 @default.
• W3136015194 hasConcept C2778137410 @default.
• W3136015194 hasConcept C2779093199 @default.
• W3136015194 hasConcept C2779652045 @default.
• W3136015194 hasConcept C2910862244 @default.
• W3136015194 hasConcept C39389867 @default.
• W3136015194 hasConcept C41895202 @default.
• W3136015194 hasConcept C556758197 @default.
• W3136015194 hasConcept C71924100 @default.
• W3136015194 hasConcept C98184364 @default.
• W3136015194 hasConcept C98274493 @default.
• W3136015194 hasConceptScore W3136015194C10138342 @default.
• W3136015194 hasConceptScore W3136015194C120757647 @default.
• W3136015194 hasConceptScore W3136015194C126322002 @default.
• W3136015194 hasConceptScore W3136015194C138885662 @default.
• W3136015194 hasConceptScore W3136015194C144133560 @default.
• W3136015194 hasConceptScore W3136015194C162324750 @default.
• W3136015194 hasConceptScore W3136015194C2778137410 @default.
• W3136015194 hasConceptScore W3136015194C2779093199 @default.
• W3136015194 hasConceptScore W3136015194C2779652045 @default.
• W3136015194 hasConceptScore W3136015194C2910862244 @default.
• W3136015194 hasConceptScore W3136015194C39389867 @default.
• W3136015194 hasConceptScore W3136015194C41895202 @default.
• W3136015194 hasConceptScore W3136015194C556758197 @default.
• W3136015194 hasConceptScore W3136015194C71924100 @default.
• W3136015194 hasConceptScore W3136015194C98184364 @default.
• W3136015194 hasConceptScore W3136015194C98274493 @default.
• W3136015194 hasLocation W31360151941 @default.
• W3136015194 hasOpenAccess W3136015194 @default.
• W3136015194 hasPrimaryLocation W31360151941 @default.
• W3136015194 hasRelatedWork W1974111008 @default.
• W3136015194 hasRelatedWork W2099080670 @default.
• W3136015194 hasRelatedWork W2215267898 @default.
• W3136015194 hasRelatedWork W222861331 @default.
• W3136015194 hasRelatedWork W2316618552 @default.
• W3136015194 hasRelatedWork W2319068972 @default.
• W3136015194 hasRelatedWork W2326342672 @default.
• W3136015194 hasRelatedWork W2397497215 @default.
• W3136015194 hasRelatedWork W2546989492 @default.
• W3136015194 hasRelatedWork W2558966 @default.
• W3136015194 hasRelatedWork W2736163569 @default.
• W3136015194 hasRelatedWork W2757281165 @default.
• W3136015194 hasRelatedWork W2917391571 @default.
• W3136015194 hasRelatedWork W2960893193 @default.
• W3136015194 hasRelatedWork W2992765306 @default.
• W3136015194 hasRelatedWork W3209791633 @default.
• W3136015194 hasRelatedWork W251231938 @default.
• W3136015194 hasRelatedWork W2601865424 @default.
• W3136015194 hasRelatedWork W311833277 @default.
• W3136015194 hasRelatedWork W3121904556 @default.
• W3136015194 isParatext "false" @default.
• W3136015194 isRetracted "false" @default.
• W3136015194 magId "3136015194" @default.
• W3136015194 workType "article" @default.